Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 319
Selected: 0
NCT IDTitle
NCT03618017The ConnectedCancerCare Pilot Study (CCC)
NCT00141726Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
NCT04845035Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT00151073Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
NCT05965180Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
NCT06234748Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
NCT00399321A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer
NCT06094621Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery
NCT03101566Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
NCT00843375Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT00763490Trial Of Double Umbilical Cord Blood Transplantation
NCT05867667Cardiac Rehabilitation to Improve Breast Cancer Outcomes
NCT02037230Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas
NCT04858256Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
NCT05866302Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
NCT00230399Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer
NCT01700010Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer
NCT00176735Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer
NCT01663272A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer
NCT01700036A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease
NCT00146029Companion Pharmacogenetic Study to UMCC 9900/9901
NCT03168152Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma
NCT02145403Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
NCT03121287Early Imaging Biomarkers in NSCLC
NCT04503668Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
NCT02946008Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer
NCT00146042UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer
NCT00156312Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
NCT00141700Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma
NCT02649530A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma
NCT05583422Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT04203160Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
NCT04827459Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors
NCT02097732Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
NCT01642732Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
NCT05070299Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study
NCT02138578Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma
NCT00320749Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
NCT03785873Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
NCT01661088A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients
NCT00726180Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer
NCT03829722Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
NCT00148070Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer
NCT03787680Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)
NCT00148135Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
NCT03161665Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation
NCT00151047Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
NCT00599131Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)
NCT01409681A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer
NCT02400463A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome